Chiropractors in Odon, IN Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Chelsea Lannan, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 |
 Wellnessfirst Chiropractic Of Odon Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 |
Odon Family Chirpractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 Fax: 812-636-7839 |
Hawkins Health Center Of Odon Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 |
 Daniel Lee Grotzinger, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 |
Lannan Family Chiropractic, Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 S Spring St, Odon, IN 47562 Phone: 812-636-8101 Fax: 812-636-7839 |
News Archive
Research findings may provide new treatment for prevention of cancer metastasis
Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.
Genetic testing for breast or ovarian cancer risk may be greatly underutilized
Although a test for gene mutations known to significantly increase the risk of hereditary breast or ovarian cancer has been available for more than a decade, a new study finds that few women with family histories of these cancers are even discussing genetic testing with their physicians or other health care providers.
Accuray announces treatment of first patient with new TomoHDA System
Accuray Incorporated, announced today the first patient has been treated with its new TomoHDA System at Centre Oscar Lambret in Lille, France.
Santen's VEKTIS study demonstrates efficacy and tolerability of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivis, over 12 months
Santen EMEA is delighted to announce that the results of VEKTIS, a twelve month study in pediatric vernal keratoconjunctivitis have been published in the American Journal of Ophthalmology.
› Verified 8 days ago